XAVIER HARRISON: Open Payments
NPI 1477582807 · HUNTERSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,078 in 139 payments from 47 companies in 2025. Trend: 2023 $2,798 · 2024 $2,740 · 2025 $4,078
Food & beverage: $3,097Long term medical supply or device loan: $981
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $1,288 |
| Janssen Biotech, Inc. | 8 | $195 |
| AstraZeneca Pharmaceuticals LP | 8 | $164 |
| Exelixis Inc. | 5 | $137 |
| GENZYME CORPORATION | 4 | $129 |
| ARRAY BIOPHARMA INC | 7 | $121 |
| ABBVIE INC. | 5 | $119 |
| Lilly USA, LLC | 5 | $118 |
| Eisai Inc. | 5 | $116 |
| BeOne Medicines USA, Inc. | 4 | $101 |
Products named: KISQALI, CABOMETYX, VERZENIO, Lenvima, SARCLISA, KEYTRUDA, LORBRENA, BRUKINSA.
Industry payments across NC — which companies pay providers there.
